7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 
      
    		                                                      
      operating activities
    		                                                      
      net income
    		22,616,000 12,235,000 8,150,000 6,866,000 15,343,000 5,073,000 5,420,000 3,311,000 15,019,000 9,613,000 5,123,000 4,081,000 -7,757,000 -4,251,000 -11,950,000 13,379,000 -6,344,000 -6,112,000 -10,500,000 -19,544,000 -48,484,000 -30,047,000 -59,411,000 21,352,000 10,896,000 13,836,000 12,487,000 3,771,000 7,502,000 10,255,000 12,067,000 8,698,000 2,898,000 1,809,000 -887,000 12,076,000 4,384,000 10,683,000 12,177,000 26,245,000 10,514,000 26,380,000 1,485,000 22,514,000 5,297,000 12,679,000 14,990,000 11,080,000 2,588,000 6,329,000  -7,447,000 -4,571,000 -4,780,000 
      adjustments to reconcile net income to cash from operating activities:
    		                                                      
      depreciation and amortization
    		15,606,000 15,896,000 14,913,000 16,601,000 14,900,000 18,838,000 15,164,000 13,545,000 19,279,000 13,878,000 13,320,000 13,998,000 15,640,000 14,282,000 12,741,000 15,512,000 14,899,000 12,685,000 12,986,000 12,312,000 14,112,000 11,930,000 15,252,000 17,987,000 15,696,000 15,593,000 14,211,000 15,453,000 13,950,000 14,513,000 13,521,000 27,040,000 14,413,000 13,266,000 12,088,000 12,306,000 12,115,000 11,626,000 10,438,000 11,612,000 10,467,000 11,091,000 9,633,000 9,819,000 7,992,000 8,084,000 8,038,000 9,200,000 7,466,000 7,143,000 -12,776,262 6,563,000 3,236,000 2,995,000 
      amortization of deferred financing costs
    		508,000 492,000 492,000 491,000 493,000 493,000 492,000 493,000 492,000 625,000 625,000 712,000 712,000 730,000 1,023,000 764,000 741,000                                      
      credit loss expense (reversal)
    		           398,000 808,000                                          
      write-downs, including asset impairments
    		256,000 854,000 193,000 939,000 635,000 2,290,000 109,000                                                
      deferred income tax expense
    		662,000      571,000           -125,000 158,000 476,000   5,627,000                                
      share-based and other non-cash compensation
    		6,283,000 7,492,000 5,275,000 5,948,000 5,508,000 6,970,000 4,783,000 6,400,000 5,297,000 7,398,000 5,135,000 8,063,000 5,544,000 7,777,000 6,189,000 7,521,000 6,226,000 6,911,000 5,421,000 5,693,000 5,495,000                                  
      unrealized foreign currency exchange gain
    		      33,000         -299,000      89,000 223,000     225,000 -67,000 438,000 35,000  -401,000 -291,000 -171,000             668,000 -1,388,000 -3,015,000     
      realized and unrealized investment gain
    		-34,000 -33,000 -32,000 -33,000 -32,000                                                  
      changes in assets and liabilities:
    		                                                      
      accounts receivable
    		17,571,000 -3,688,000 -15,014,000 6,104,000 8,509,000 18,994,000 -4,502,000 485,000 -11,923,000 -2,843,000 12,374,000 -10,953,000 -3,305,000 -12,091,000 -2,654,000 -28,117,000 -13,287,000 2,695,000 -13,744,000 3,247,000 -6,621,000                                  
      inventories
    		-4,560,000 -5,059,000 1,032,000 4,680,000 90,000 -1,599,000 -4,672,000 13,486,000 -7,653,000 -172,000 -5,946,000 4,602,000 -3,182,000 -6,415,000 -534,000 10,798,000 -1,214,000 1,430,000 437,000 11,915,000 6,609,000                                  
      film assets
    		-5,117,000 -3,922,000 -7,396,000 -7,230,000 -5,151,000 -7,829,000 -4,912,000 -5,819,000 -5,334,000 -5,357,000 -3,884,000 -5,424,000 -3,754,000 -5,313,000 -5,107,000 -4,775,000 -4,227,000 -3,595,000 -2,213,000 -1,488,000 -2,120,000                                  
      deferred revenue
    		8,608,000 1,726,000 1,390,000 -915,000 -8,996,000 1,678,000 -6,075,000 788,000 -1,415,000 -5,861,000 2,606,000 -5,583,000 -698,000 -4,461,000 -830,000 -5,157,000 -987,000 -5,723,000 5,276,000 -11,870,000 -4,566,000                                  
      changes in other operating assets and liabilities
    		4,410,000 -2,085,000 -2,215,000 -21,421,000 5,315,000 -1,702,000 -17,384,000 -31,848,000 15,002,000 -10,799,000 -8,344,000 4,349,000 4,131,000 2,507,000 -10,186,000 9,548,000 5,233,000 -12,980,000 -4,155,000 -531,000 -11,889,000                                  
      net cash from operating activities
    		67,513,000 23,230,000 6,951,000 11,485,000 35,282,000 35,038,000 -10,968,000 4,007,000 28,753,000 4,637,000 21,218,000 16,840,000 5,774,000 -1,510,000 -3,783,000 25,647,000 -2,566,000 -6,065,000 -10,951,000 7,807,000 -9,938,000 -26,846,000 5,966,000 23,119,000 18,740,000 49,186,000 -669,000 41,902,000 21,416,000 31,191,000 15,463,000 21,947,000 26,199,000 37,837,000 -617,000 32,568,000 9,237,000 31,103,000 4,964,000 41,885,000 23,302,000 12,429,000 6,069,000 14,735,000 36,620,000 19,720,000 34,068,000 9,416,000 10,426,000 12,656,000 4,976,779 256,000 -5,857,000 618,000 
      capex
    		-2,744,000 -2,361,000 -1,645,000 -4,612,000 -1,126,000 -1,586,000 -1,104,000 -3,950,000 -1,532,000 -645,000 -364,000 -3,176,000 -2,314,000 -2,206,000 -728,000 -1,237,000 -988,000 -899,000 -466,000 -39,000 -64,000 -323,000 -271,000 -1,893,000 -1,353,000 -1,938,000 -2,237,000 -6,001,000 1,265,000 -2,044,000 -6,588,000 -7,787,000 -6,585,000 -5,703,000 -4,068,000 -5,245,000 -1,561,000 -3,887,000 -4,585,000 -4,814,000 -3,523,000 -12,338,000 -22,582,000 -15,418,000 -8,105,000 -3,456,000 -824,000 -1,401,000 -374,000 -1,119,000 0 -610,000 -624,000 -99,000 
      free cash flows
    		64,769,000 20,869,000 5,306,000 6,873,000 34,156,000 33,452,000 -12,072,000 57,000 27,221,000 3,992,000 20,854,000 13,664,000 3,460,000 -3,716,000 -4,511,000 24,410,000 -3,554,000 -6,964,000 -11,417,000 7,768,000 -10,002,000 -27,169,000 5,695,000 21,226,000 17,387,000 47,248,000 -2,906,000 35,901,000 22,681,000 29,147,000 8,875,000 14,160,000 19,614,000 32,134,000 -4,685,000 27,323,000 7,676,000 27,216,000 379,000 37,071,000 19,779,000 91,000 -16,513,000 -683,000 28,515,000 16,264,000 33,244,000 8,015,000 10,052,000 11,537,000 4,976,779 -354,000 -6,481,000 519,000 
      investing activities
    		                                                      
      purchase of property, plant and equipment
    		-2,744,000 -2,361,000 -1,645,000 -4,612,000 -1,126,000 -1,586,000 -1,104,000 -3,950,000 -1,532,000 -645,000 -364,000 -3,176,000 -2,314,000 -2,206,000 -728,000 -1,237,000 -988,000 -899,000 -466,000 -39,000 -64,000 -323,000 -271,000 -1,893,000 -1,353,000 -1,938,000 -2,237,000 -6,001,000 1,265,000 -2,044,000 -6,588,000 -7,787,000 -6,585,000 -5,703,000 -4,068,000 -5,245,000 -1,561,000 -3,887,000 -4,585,000 -4,814,000 -3,523,000 -12,338,000 -22,582,000 -15,418,000 -8,105,000 -3,456,000 -824,000 -1,401,000 -374,000 -1,119,000  -610,000 -624,000 -99,000 
      investment in equipment for joint revenue sharing arrangements
    		-9,448,000 -2,920,000 -11,746,000 -2,613,000 -11,971,000 -5,315,000 -4,442,000 -7,295,000 -6,672,000 -1,876,000 -2,157,000 -5,260,000 -5,892,000 -4,064,000 -4,587,000 -4,733,000 -2,964,000 -857,000 -1,540,000 -1,365,000                                   
      acquisition of other intangible assets
    		-539,000 -2,143,000 -1,233,000 -3,645,000 -1,611,000 -1,597,000 -1,594,000 -2,926,000 -1,940,000 -1,718,000 -1,760,000 -1,148,000 -1,566,000 -1,129,000 -551,000 -693,000 -768,000 -1,124,000 -1,507,000 -243,000 -440,000 -359,000 -862,000 -1,057,000 -753,000 -581,000 -540,000 -5,498,000 -1,493,000 -1,150,000 -555,000 -1,275,000 -1,315,000 -1,033,000 -1,591,000 -1,856,000 -1,240,000 -921,000 -770,000 -1,443,000 -650,000 -2,307,000 -665,000 -939,000 -1,009,000 -780,000 -823,000 -1,655,000 -2,568,000 -18,198,000     
      net cash from investing activities
    		-12,731,000 -7,424,000 -14,624,000 -10,870,000 -14,708,000 -8,498,000 -7,140,000 -13,126,000 -10,144,000 -4,239,000 -4,281,000 -12,884,000 -22,411,000 -7,399,000 -10,597,000 -6,663,000 -4,720,000 -2,880,000 14,256,000 -1,647,000 -1,885,000 -3,010,000 -2,713,000 -12,340,000 -10,970,000 -15,038,000 -27,646,000 -23,599,000 -14,483,000 -6,839,000 -11,953,000 -16,264,000 -25,888,000 -17,239,000 -14,206,000 -26,398,000 -7,625,000 -21,520,000 -9,343,000 -13,762,000 -15,529,000 -21,443,000 -28,062,000 -16,780,000 -16,721,000 -12,319,000 -3,797,000 -8,992,000 -10,411,000 -31,087,000 2,253,263 -900,000 -862,000 -492,000 
      financing activities
    		                                                      
      revolving credit facility borrowings
    		56,000,000 6,000,000 23,000,000  4,000,000 6,000,000 45,000,000  315,000 5,000,000 25,717,000 32,981,000    0 0                                      
      repayments of revolving credit facility borrowings
    		-75,000,000 -8,000,000 -10,000,000 -10,000,000 -11,000,000   -10,191,000 -4,171,000 -7,706,000 -31,180,000 0    -7,366,000 0 -45,243,000 -255,000,000                                    
      credit facility amendment fees paid
    		           -2,000 -249,000 -245,000 -1,783,000 -53,000 -442,000 0 -32,000 -47,000 -67,000       0 54,000           -223,000 -149,000 -158,000 -1,003,000       -9,000     
      repayments of other borrowings
    		-166,000 -163,000 -209,000  -178,000                                                  
      repurchase of common shares
    		    0 -246,000 -17,856,000  -252,000 -355,000 -3,656,000         0 0 0 -36,624,000 0 -1,401,000   -25,027,000 0 -33,056,000 -13,396,000 -2,000 0   -16,140,000 -14,664,000 -41,096,000 -44,618,000 3,000    -694,000           
      repurchase of common shares - imax china
    		0                                                      
      taxes withheld and paid on employee stock awards vested
    		0 -237,000 -9,505,000 0 0 -784,000 -4,194,000 -8,000 0 -225,000 -6,233,000 -294,000 0 -257,000 -3,136,000 -615,000 0 0 -3,045,000 -261,000 0 -15,000 -236,000 -82,000 -289,000 0 -219,000 0 -158,000 -251,000 -1,028,000 -382,000 -31,000 -41,000 -146,000 -298,000 -157,000                  
      common shares issued - stock options exercised
    		346,000 100,000 948,000 5,193,000            0 0 59,000 824,000     13,000 12,000 1,576,000 803,000          3,614,000 2,842,000 740,000    11,407,000 7,162,000           
      principal payment under finance lease obligations
    		   -29,000    0    -58,000 0                                          
      net cash from financing activities
    		-20,861,000 -3,754,000 4,234,000 -5,090,000 -7,560,000 -16,185,000 22,794,000  -4,588,000 -4,724,000 -15,037,000 6,081,000 -7,085,000 -44,475,000 -13,035,000 -22,233,000 -13,917,000 -43,925,000 -52,645,000 7,058,000 -2,165,000 -3,489,000 239,163,000 -3,746,000 -12,107,000 -50,888,000 9,623,000 -10,862,000 -6,013,000 -37,347,000 -16,640,000 -4,347,000 -823,000 -52,865,000 499,000 -19,497,000 -11,707,000 -41,360,000 -53,218,000 171,398,000 -37,238,000 15,185,000 55,870,000 14,811,000 -1,354,000 -15,597,000 -24,208,000 1,551,000 3,405,000  1,934,706 -513,000   
      effects of exchange rate changes on cash
    		-66,000 130,000 -84,000 563,000 -62,000 180,000 131,000 -103,000 316,000 346,000 -55,000     -48,000 86,000 -799,000 -245,000 -1,036,000 199,000 54,000 377,000 -97,000 434,000 107,000 186,000 534,000 -347,000 458,000 -16,000 -319,000 -24,000 30,000 46,000 -18,000 118,000 106,000 -100,000 567,000 443,000 -130,000 -38,000 32,000 73,000 82,000 -193,000 17,000 30,000 6,000 -30,970 53,000 -25,000 3,000 
      increase in cash and cash equivalents during period
    		33,855,000 12,182,000 -3,523,000  12,952,000 10,535,000 4,817,000    1,845,000      -21,117,000 -53,669,000 -49,585,000  -13,789,000 -33,291,000 242,793,000              -9,977,000 -31,671,000 -57,697,000                
      cash and cash equivalents, beginning of period
    		0 0 100,592,000  0 0 76,200,000  0 0 97,401,000  0 0 189,711,000  0 0 317,379,000  0 0 109,484,000  0 0 141,590,000  0 0 158,725,000  0 0 204,759,000  0 0 317,449,000  0 0 106,503,000  0  0 0 18,138,000   0 0 25,123,000 
      cash and cash equivalents, end of period
    		33,855,000 12,182,000 97,069,000  12,952,000 10,535,000 81,017,000  14,337,000 -3,980,000 99,246,000  -22,961,000 -52,188,000 162,300,000  -21,117,000 -53,669,000 267,794,000  -13,789,000 -33,291,000 352,277,000  -3,903,000 -16,633,000 123,084,000  573,000 -12,537,000 145,579,000  -536,000 -32,237,000 190,481,000  -9,977,000 -31,671,000 259,752,000  -29,022,000 6,041,000 140,342,000  18,618,000  5,870,000 1,992,000 21,588,000   -329,000 -8,942,000 25,252,000 
      credit loss (reversal) expense
    		 -183,000 -126,000 -10,000            933,000 -3,317,000                                      
      unrealized foreign currency exchange (gain) loss
    		   -2,243,000       -78,000         -961,000      10,000 -24,000          377,000 -26,000 -557,000       -177,000         
      unrealized foreign currency exchange loss
    		  289,000      -123,000      58,000    113,000                     69,000 -135,000 -500,000 1,351,000  783,000          
      deferred income tax benefit
    		   1,708,000 383,000    -445,000 -3,086,000 -193,000                                            
      interest in film classified as a financial instrument
    		           0 0 0 -4,731,000                                        
      proceeds from sale of equity securities
    		                 0 17,769,000                                    
      acquisition of ssimwave, net of cash and cash equivalents acquired
    		                                                      
      proceeds from revolving credit facility borrowings
    		                                                      
      proceeds from other borrowings
    		                                                      
      repayment of other borrowings
    		      -156,000                                                
      repurchase of common shares, imax corporation
    		           -26,543,000 -4,226,000 -43,083,000 -6,272,000                                        
      repurchase of common shares, imax china
    		           0 -1,199,000 0 -1,844,000 -5,044,000    0 -2,000 -641,000 -891,000 -5,000 -2,344,000                              
      dividends paid to non-controlling interests
    		       0 0   -3,000     -2,928,000   0 -2,096,000   0 -2,118,000                              
      increase in cash and cash equivalents during year
    		                                                      
      cash and cash equivalents, beginning of year
    		                                                      
      cash and cash equivalents, end of year
    		                                                      
      credit loss expense
    		     139,000 35,000  523,000 846,000 220,000    7,229,000    305,000 3,026,000 3,925,000 1,440,000 10,217,000                                
      realized and unrealized investment gains
    		      -30,000    -44,000  -35,000 -30,000 -34,000                                        
      other borrowings
    		        0 0 315,000                                            
      deferred income tax (benefit) expense
    		             -191,000 -109,000                                        
      acquisition of ssimwave inc., net of cash and cash equivalents acquired
    		                                                      
      proceeds from issuance of convertible notes
    		               0 0 0 223,675,000                                    
      debt issuance costs related to convertible notes
    		               2,000 -921,000                                      
      purchase of capped calls related to convertible notes
    		               0 0 0 -19,067,000                                    
      net cash from by financing activities
    		                                                      
      decrease in cash and cash equivalents during year
    		                                                      
      write-downs
    		        398,000 170,000 304,000  275,000 5,051,000 381,000 886,000 416,000 249,000 213,000 4,390,000 6,533,000 2,403,000 4,403,000                            -686,683 718,000 -31,000 6,000 
      unrealized investment gains
    		        -364,000                                              
      decrease in cash and cash equivalents during period
    		            -22,961,000 -52,188,000 -27,411,000          -3,903,000 -16,633,000 -18,506,000  573,000 -12,537,000 -13,146,000  -536,000 -32,237,000 -14,278,000                    
      realized and unrealized investment (gains) losses
    		               -29,000 -30,000 -33,000 -5,248,000                                    
      equity in losses of investees
    		                    1,329,000 0 529,000                                
      treasury stock purchased for future settlement of restricted share units
    		                          -4,207,000  1,039,000 1,356,000 -5,992,000  1,026,000 -4,633,000 -779,000  7,000                  
      effects of exchange rate changes on cash and cash equivalents
    		            761,000 1,196,000 4,000                                        
      equity in losses (income) of investees
    		                                                      
      proceeds from sale of (investment in) equity securities
    		                                                      
      issuance of subsidiary shares to non-controlling interests
    		                       0 0                   4,060,000 0          
      dividends paid to imax china non-controlling interests
    		                                                      
      proceeds from sale of equity investment
    		                                                      
      settlement of restricted share units and options
    		                   -260,000 -58,000 -1,090,000 -1,667,000 -1,206,000 -970,000 -2,632,000 -4,987,000 1,651,000 -1,038,000 -1,356,000 -173,000 -4,965,000 -1,318,000 -2,890,000 -11,158,000 -9,513,000 -7,000                  
      treasury stock repurchased for future settlement of restricted share units
    		                   260,000 58,000 1,090,000 -1,419,000 -2,466,000 3,000                              
      cash provided by:
    		                                                      
      adjustments to reconcile net income to cash from operations:
    		                                                      
      loss in fair value of investments
    		                   1,142,000                                   
      investment in equity securities
    		                       0 0 0 -15,153,000                            
      increase in revolving credit facility borrowings
    		                   7,366,000                                   
      repayment of revolving credit facility borrowings
    		                                                      
      loss in fair value of equity securities
    		                                                      
      purchase of equipment for joint revenue sharing arrangements
    		                     -2,328,000 -1,580,000                                
      increase in credit facility borrowings
    		                                                      
      repayment of credit facility borrowings
    		                                                      
      share and other non-cash compensation
    		                      4,309,000                                
      change in fair value of equity securities
    		                      4,539,000                                
      investment in film assets
    		                      -3,064,000 -8,032,000 -7,191,000 -4,474,000 -3,740,000 -960,000 -4,021,000 -11,960,000 -6,259,000 -3,959,000 -11,097,000 -16,255,000 -3,334,000 -8,146,000 -3,272,000 -6,971,000 -3,919,000 -3,050,000 -4,665,000 -4,391,000 -3,013,000 -10,835,000 -3,251,000 -3,309,000 -2,367,000 -7,183,000 -3,958,000 -3,442,000 8,153,619 -2,575,000 -4,250,000 -1,340,000 
      changes in other non-cash operating assets and liabilities
    		                      23,342,000 -21,643,000 -7,757,000 10,576,000 -27,105,000 12,790,000 -129,000 9,604,000 -9,818,000 -20,294,000 3,269,000 25,164,000 -17,280,000 -1,370,000 -14,105,000 7,347,000 -22,746,000 4,678,000 -1,985,000 -29,466,000 -9,805,000 -12,315,000 21,591,000 -6,590,000 3,097,000 -11,914,000 145,000 -1,187,000 -5,819,976 3,501,000 188,000 2,139,000 
      increase in bank indebtedness
    		                      280,000,000 0 0 0 35,000,000 30,000,000            7,722,000 0 6,197,000 11,371,000   0 0 5,000,000 4,917,000 15,500,000     
      repayment of bank indebtedness
    		                       0 -5,000,000 -35,000,000 -15,000,000 -10,000,000 -39,667,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000 -500,000       -19,000,000 -25,000,000 -5,000,000 -5,000,000 0     
      write-downs, net of recoveries
    		                       3,822,000 1,118,000 1,169,000 697,000 9,229,000 855,000 650,000 1,036,000 3,948,000 12,465,000 9,145,000 4,010,000 3,037,000 1,654,000 601,000 648,000 797,000 1,471,000 1,329,000 128,000 3,541,000 174,000 91,000 597,000 438,000 481,000 1,113,000     
      deferred income taxes
    		                                                      
      stock and other non-cash compensation
    		                       6,173,000 5,687,000 7,186,000 4,524,000 5,483,000 6,320,000 6,779,000 5,141,000 5,159,000 6,346,000 6,910,000 5,660,000 8,690,000 7,882,000 6,347,000 8,667,000 7,175,000 4,343,000 5,195,000 5,666,000 3,858,000 3,519,000 3,439,000 2,931,000 3,868,000 3,982,000 2,841,000 -3,054,211 1,053,000 197,000 1,809,000 
      income from equity-accounted investments
    		                       -59,000 368,000 238,000 183,000 -114,000 103,000 0 106,000 -233,000 218,000 165,000 156,000 -84,000 789,000 1,162,000 818,000 1,082,000 833,000 1,138,000 785,000 701,000 499,000 324,000 334,000        
      (gain) loss on non-cash contribution to equity-accounted investees
    		                       0 -534,000 -100,000 -99,000                            
      investment in joint revenue sharing equipment
    		                       -9,390,000 -8,864,000 -12,519,000 -9,716,000 -12,100,000 -14,255,000 -3,645,000 -4,810,000 -7,096,000 -17,988,000 -10,003,000 -7,547,000 -17,386,000 -4,824,000 -16,712,000 -3,988,000 -7,505,000 -9,356,000 -6,798,000 -4,815,000 -930,000 -5,107,000 -8,083,000 -2,150,000 -5,936,000 -7,088,000 -10,858,000     
      change in deferred income taxes
    		                        -261,000 608,000 688,000 -4,074,000 -3,196,000 812,000 -465,000 1,128,000 -2,012,000 -2,175,000 -958,000 5,457,000 -488,000 156,000 -185,000 -6,433,000 2,865,000 2,041,000 191,000 -2,530,000 368,000 5,179,000 5,880,000 3,014,000 651,000 2,395,000   -73,000 -76,000 
      change in fair value of equity investment
    		                        490,000                              
      movement in fair value of financial instruments
    		                          -2,491,000                            
      repurchase of subsidiary shares from a non-controlling interest
    		                          -1,767,000                            
      issuance of subsidiary shares to a non-controlling interest
    		                            850,000 2,247,000 4,449,000          0 0 40,000,000            
      gain on non-cash contribution to equity-accounted investees
    		                               99,000 100,000 99,000 99,000 -66,000 -99,000 178,000 -377,000 -290,000 -406,000 -388,000 -352,000 -351,000      0     
      investment in new business ventures
    		                               -106,000 0 -500,000 -1,000,000     0    0  0 0 0 -381,000 -912,000     
      common shares issued—stock options exercised
    		                           0      1,337,000 13,082,000                    
      taxes paid on secondary sales and repatriation dividend
    		                                                      
      loss on non-cash contribution to equity-accounted investees
    		                            99,000 100,000 99,000                        
      dividend paid to non-controlling shareholders
    		                            -2,311,000                          
      exercise of stock options
    		                                       11,771,000               
      issuance of subsidiary shares to non-controlling interests - private offering
    		                                                      
      share issuance costs from the issuance of subsidiary shares to non-controlling interests - private offering
    		                                                      
      issuance of subsidiary shares to non-controlling interests - public offering
    		                                                      
      share issuance expenses - public offering
    		                                                      
      taxes paid on secondary sale and repatriation dividend
    		                                    0 0 -2,991,000                
      income from discontinued operations, net of tax
    		                                                      
      net cash from operating activities from discontinued operations
    		                                           0 0      773,692    
      proceeds from sale of business venture
    		                                                      
      settlement of restricted share units
    		                                      -5,849,000   -1,083,000 -3,905,000 0 0          
      gain on curtailment of postretirement benefit plan
    		                                                      
      treasury stock repurchased for settlement of share based compensation
    		                                                      
      net income from discontinued operations
    		                                                      
      share issuance costs from the issuance of subsidiary shares to a non-controlling interest
    		                                        0 0 -2,000,000            
      treasury stock purchased for settlement of share based compensation
    		                                                      
      increase in cash and cash equivalents during the period
    		                                        -29,022,000 6,041,000 33,839,000  18,618,000  5,870,000 1,992,000 3,450,000      
      common shares issued — stock options exercised
    		                                                3,488,000      
      share issuance costs from the issuance of subsidiary shares to non-controlling interests
    		                                           0 0          
      proceeds from disgorgement of stock sale profits
    		                                                      
      share issuance expenses
    		                                                      
      net (income) income from discontinued operations
    		                                            0          
      benefit from arbitration award
    		                                                 0     
      gain on curtailment of postretirement benefits
    		                                                      
      change in cash surrender value of life insurance
    		                                                      
      cash surrender value of life insurance
    		                                                      
      acquisition of other assets
    		                                                      
      loss on equity-accounted investments
    		                                                459,000      
      items not involving cash:
    		                                                      
      loss on repurchase of senior notes due december 2010
    		                                                      
      repurchase of senior notes due december 2010
    		                                                      
      common shares issued—public offerings, net of offering expenses paid
    		                                                      
      common shares issued— stock options exercised
    		                                                      
      shelf registration fees paid
    		                                                      
      net cash provided (used in) by financing activities
    		                                                      
      foreign currency exchange (gain) loss
    		                                                      
      net earnings
    		                                                      
      gain on sale of property, plant and equipment
    		                                                      
      proceeds from sale of property, plant and equipment
    		                                                      
      common shares issued — public offerings, net of offering expenses paid
    		                                                      
      common shares issued — private offering
    		                                                      
      debt modification fees paid
    		                                                      
      fees paid pertaining to amended credit facility agreement
    		                                                      
      foreign currency exchange gain
    		                                                      
      gain on repurchase of senior notes due december 2010
    		                                                      
      investment in joint venture
    		                                                      
      repayments of bank indebtedness
    		                                                      
      purchases of short-term investments
    		                                                  6,450,543 -2,182,000 -2,151,000 -2,124,000 
      proceeds from maturities of short-term investments
    		                                                  -6,439,428 2,174,000 2,150,000 2,124,000 
      net cash from investing activities from discontinued operations
    		                                                      
      financing costs related to senior notes due 2010
    		                                                  2,082,570 -653,000   
      net income (income) from discontinued operations
    		                                                      
      write-downs net of recoveries
    		                                                      
      common shared issued — public offering
    		                                                      
      increase in cash and cash equivalents, during the period
    		                                                      
      foreign currency exchange loss
    		                                                      
      net earnings from discontinued operations
    		                                                      
      accrued interest on short-term investments
    		                                                      
      debt modification fees
    		                                                      
      increase in cash and cash equivalents, during the year
    		                                                     129,000 
      common shares issued - private offering
    		                                                      
      receivable provisions, net of recoveries
    		                                                      
      common shares issued
    		                                                  -147,580 140,000   
      purchase of property, plant and equipment, net of proceeds
    		                                                      
      recovery of deferred income tax valuation allowance
    		                                                      
      non-cash foreign exchange gain
    		                                                   -502,000 -514,000 -109,000 
      interest on short-term investments
    		                                                   -19,000 -23,000 -26,000 
      increase in cash surrender value of life insurance
    		                                                      
      increase in other assets
    		                                                   -187,000 -129,000 -245,000 
      increase in other intangible assets
    		                                                   -95,000 -108,000 -148,000 
      decrease in cash and cash equivalents, during the period
    		                                                   -329,000   
      net (earnings) from discontinued operations
    		                                                      
      (increase) in cash surrender value of life insurance
    		                                                      
      decrease in cash and cash equivalents from continuing operations
    		                                                      
      increase in cash and cash equivalents provided by discontinued operations
    		                                                      
      increase in cash and cash equivalents from continuing operations
    		                                                     129,000 
      increase in cash and cash equivalents provided by investing activities from discontinued operations
    		                                                      
      loss on retirement of notes
    		                                                      
      non-cash foreign exchange (gain) loss
    		                                                      
      premium on repayment of notes
    		                                                      
      changes in restricted cash
    		                                                      
      recovery on long-term investments
    		                                                      
      repayment of old senior notes due 2005
    		                                                      
      increase in cash and cash equivalents from discontinued operations
    		                                                      
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.